Pembrolizumab Works Better Than Chemotherapy Alone As Initial Treatment For Nsclc

Dr Lopes speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about results from a trial that show front line pembrolizumab surpassed chemotherapy for lung cancer patients whose tumours had PD-L1 expression and no EGFR/ALK rearrangements.

For more on these results, watch Dr Lopes present the data in a press conference here and read our news coverage here.
ecancer.org/conference/1049-2018-asco-annual-meeting/video/6912/pd-1-immunotherapy-better-than-chemo-alone-as-first-line-lung-cancer-treatment.php
ecancer.org/news/14118.php

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

  • Pembrolizumab works better than chemotherapy alone as initial treatment for NSCLC ( Download)
  • First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year fol... ( Download)
  • Actual Use of Pembrolizumab and Chemotherapy in NSCLC ( Download)
  • Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC) ( Download)
  • Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer treatment ( Download)
  • PD-1 immunotherapy better than chemo alone as first line lung cancer treatment ( Download)
  • Latest data from KEYNOTE 42: Pembrolizumab vs chemotherapy in treatment-naive patients (pts) wit... ( Download)
  • Implications for Pembrolizumab in NSCLC ( Download)
  • Dr. Spigel on Pembrolizumab/Chemo Combo in First-Line NSCLC ( Download)
  • Chemotherapy + Pembrolizumab: A New Standard of Care ( Download)
  • New Lung Cancer Clinical Trial: Pembrolizumab for Stage IIIB Lung Cancer AJCC v8 ( Download)
  • Squamous cell carcinoma of the lung: Treatment options in first- and second line ( Download)
  • Advanced NSCLC: Refining Clinical Pathways in the Rapidly Evolving Therapeutic Landscape ( Download)
  • Pembrolizumab Treatment in Stage III NSCLC and Alternatives ( Download)
  • Clinical Trial for Early-Stage Non-Small Cell Lung Cancer Following Surgery ( Download)

Author

Ariyani

Como educador, estou profundamente engajado no desenvolvimento dos estudantes em ambiente escolar, adotando métodos pedagógicos que valorizam conexões genuínas e são movidos por inovação e fervor. É minha vocação guiar os alunos na jornada de se tornarem uma geração notável, empregando estratégias de ensino amplamente aclamadas por prestigiadas instituições acadêmicas ao redor do globo - events.zulekhahospitals.com